Back to BCAX

Aisling Capital Management LP → BCAX

Aisling Capital Management LP BCAX Position History

Bicara Therapeutics Inc. • Healthcare

Quarters held
4
Latest value
$10.2M
Q3 2026
Peak value
$16.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$9.6M
Q1 2026$11.3M
Q2 2026$16.9M
Q3 2026$10.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$10.2M548.9K——
Q2 2026$16.9M568.9K——
Q1 2026$11.3M568.9K——
Q4 2025$9.6M568.9K——

Other funds holding BCAX

Other Aisling Capital Management LP positions

BBIO

BridgeBio Pharma Inc. (BBIO)

$389.3M
BBIO

BridgeBio Pharma Inc. (BBIO)

$378M
BBIO

BRIDGEBIO PHARMA INC

$341.8M
BBIO

BRIDGEBIO PHARMA INC

$203.3M
MNST

MONTE ROSA THERAPEUTICS INC

$37.6M
SNDX

Syndax Pharmaceuticals, Inc. (SNDX)

$30.8M
SNDX

SYNDAX PHARMACEUTICALS INC

$28.8M
SNDX

Syndax Pharmaceuticals, Inc. (SNDX)

$27.7M